With a 5.0-star rating on Google based on over 250 reviews, Movement Room is frequently recommended as one of the top choices ...

CEPI and POP BIO are committed to enabling equitable access to the outputs of their partnership, in line with CEPI’s ...

Brent Morrison, CFA, Chairman and Chief Executive Officer of Regional, stated, “Regional is pleased that ISS concluded that support for this transaction was warranted. Regional is even more pleased ...

The Celcuity management team will host a webcast/conference call on Monday, July 28, 2025 at 8:00 a.m. ET to discuss the topline results from the Phase 3 VIKTORIA-1 trial. Those who would like to ...

The Company intends to use the net proceeds from the Offering to pay $1,500,000 for marketing and advertising services to be provided by IR Agency LLC, $1,000,000 to fund the initial milestone payment ...

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...

Dr. Shaltiel will present the Company’s exosome-based regenerative therapy platform at the Falling Walls Science Summit, taking place in Berlin, Germany from November 6-9, 2025. The winner, selected ...

Inidascamine was well-tolerated, with a favorable safety profile consistent with previous studies. Importantly, no evidence of sedation, weight gain, or extrapyramidal symptoms was observed, which are ...

The top 25 entries are now on display in the Wellcome Photography Prize 2025 exhibition, which is free and open to the public at the Francis Crick Institute in London, running until 18 October 2025.

Liminatus is working in close coordination with experienced legal, financial, and regulatory advisors to determine the optimal structure, governance, and compliance framework for the proposed ...

Webcast: A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website ( click here) or directly ( click here ). An online replay will be available on ...

Results show biopsy-proven resolution of BK polyomavirus nephropathy in kidney transplant recipients  No safety or tolerability concerns were observed Supports progression into Phase III development ...